Company intelligence / Profile preview

MMJ Group Holdings

Western Australia, Australia

Ownership: Private
Development stage: Other

Overview

MMJ Group Holdings transitioned from operating as a vertically integrated cannabis biotechnology company to a cannabis-focused listed investment company. As an owner-operator, it advanced oral delivery technologies for medical cannabis and had several programs move into commercial distribution of cannabinoid-based products, with clinical results supporting efficacy for specific products in pain and epilepsy. Since 2018, it no longer develops therapies directly but holds minority investments in multiple cannabis-related entities worldwide, leveraging its prior R&D and regulatory expertise.[4][5]

Therapeutic areas: NeurologyOther
Modalities: Small moleculeBiologic
Industry: Investors

Partnerships

Yissum (Hebrew University tech transfer)

Beyond the preview

Go deeper on MMJ Group Holdings.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on MMJ Group Holdings.

Explore the full profile